Owners, management and financials
CVR: 37110248
Previous names: Jumjum Slik ApS, Qi-Consult ApS, Ant Consulting Group ApS
DKK 4,432,157
Gross profit
Net result: DKK 1,881,849
Qi Holding APS (100%)
CVR · view owners
Kamran Khasadar
CVR · view management
Active
Founded 25 September 2015
CVR · view overview
4 employees
CVR · 2026
Name registered: CPH Pharma ApS
CVR · 24/05/2023
View the full event history
CPH Pharma ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2015. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The company was previously named Ant Consulting Group ApS and Qi-Consult ApS. The management consists of Kamran Khasadar. The company is owned by Qi Holding APS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,432,157 and a net result of DKK 1,881,849 compared with DKK 1,257,143 the year before. Equity in the 2025 report amounted to DKK 3,102,300.
Source: annual report 2025, Danish Business Authority
CPH Pharma ApS demonstrates a positive financial trajectory, with consistent growth in gross profit and profit over the past four years. Gross profit increased from 1,577,564 DKK in 2021 to 4,432,157 DKK in 2025, while profit rose from 586,524 DKK to 1,881,849 DKK in the same period, indicating strong operational efficiency and profitability. The company's equity has remained relatively stable, with a slight decline from 3,220,451 DKK in 2024 to 3,102,300 DKK in 2025, suggesting a need for careful management of financial resources. Operating within the engineering consulting sector, CPH Pharma ApS is positioned to leverage its growing profitability to strengthen its market presence, although the lack of disclosed revenue figures may raise concerns about transparency and overall financial stability.
AI-generated summary · Generated 13/08/2026
Virksomhedens formål er at drive rådgivende ingeniørvirksomhed inden for produktions- og maskinteknik.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 4.4 mio. | 1.9 mio. | 4.2 mio. | 3.1 mio. | 4 | |
| 202401/01/2024 – 31/12/2024 | 3.4 mio. | 1.3 mio. | 4.2 mio. | 3.2 mio. | 3 | |
| 202301/01/2023 – 31/12/2023 | 3 mio. | 1 mio. | 2.9 mio. | 2 mio. | 3 | |
| 202201/01/2022 – 31/12/2022 | 1.7 mio. | 587 t. | 1.9 mio. | 1.3 mio. | 2 | |
| 202101/01/2021 – 31/12/2021 | 1.6 mio. | 895 t. | 1.6 mio. | 1 mio. | 1 | |
| 202001/01/2020 – 31/12/2020 | 1 mio. | 480 t. | 719 t. | 447 t. | 1 | |
| 201901/01/2019 – 31/12/2019 | 799 t. | 575 t. | 714 t. | -33 t. | 1 | |
| 201801/01/2018 – 31/12/2018 | -104 t. | -420 t. | 39 | -607 t. | 1 | |
| 201701/01/2017 – 31/12/2017 | 80 t. | -196 t. | 535 t. | -187 t. | - |
Compared to 1.018 companies in Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of CPH Pharma ApS is 37110248.
CPH Pharma ApS is owned by Qi Holding APS.
The management of CPH Pharma ApS consists of Kamran Khasadar.
In 2025, CPH Pharma ApS reported a gross profit of DKK 4,432,157.
CPH Pharma ApS had 4 employees in 2026 according to the Danish CVR register.
CPH Pharma ApS was founded on 25 September 2015.
Claim this page to add your logo and social links. Free to get started.
CPH Pharma ApS has published its annual report for 2025. Gross profit came to DKK 4,432,157, and the net result was DKK 1,881,849.
CPH Pharma ApS has published its annual report for 2024. Gross profit came to DKK 3,353,608, and the net result was DKK 1,257,143.
CPH Pharma ApS has published its annual report for 2023. Gross profit came to DKK 3,016,998, and the net result was DKK 1,034,324.
On May 24, 2023, the company changed its name from Ant Consulting Group ApS to CPH Pharma ApS.
CPH Pharma ApS has published its annual report for 2022. Gross profit came to DKK 1,747,395, and the net result was DKK 586,524.
On December 1, 2022, the company changed its name from Qi-Consult ApS to Ant Consulting Group ApS.
CPH Pharma ApS has published its annual report for 2021. Gross profit came to DKK 1,577,564, and the net result was DKK 894,996.
CPH Pharma ApS has published its annual report for 2020. Gross profit came to DKK 1,013,451, and the net result was DKK 480,075.
As of July 15, 2020, Kamran Khasadar is registered as director of CPH Pharma ApS.
As of July 15, 2020, Faizan Khasadar has stepped down as director of CPH Pharma ApS.
CPH Pharma ApS has published its annual report for 2019. Gross profit came to DKK 798,671, and the net result was DKK 574,647.
CPH Pharma ApS has published its annual report for 2018. Gross profit came to DKK -103,613, and the net result was DKK -419,887.
On April 15, 2019, the company changed its name from Jumjum Slik ApS to Qi-Consult ApS.
As of July 1, 2018, Qi Holding APS is registered as an owner of CPH Pharma ApS with an ownership share of 100%.
CPH Pharma ApS has published its annual report for 2017. Gross profit came to DKK 80,057, and the net result was DKK -196,109.
CPH Pharma ApS has published its interim report for the period September 25, 2015 to December 31, 2016.
As of March 26, 2016, Faizan Khasadar is registered as director of CPH Pharma ApS.
As of March 26, 2016, Kamran Khasadar has stepped down as director of CPH Pharma ApS.
As of September 25, 2015, Kamran Khasadar is registered as director of CPH Pharma ApS.
CPH Pharma ApS was founded on September 25, 2015.
Companies in the same industry and area
CVR 45007871
CVR 37836036
CVR 44965275
CVR 39421003
CVR 45856526
